Polymorphisms in the dopamine transporter gene (SLC6A3/DAT1) and alcohol dependence in humans: A systematic review

Pharmacogenomics

Volumn 10, Issue 5, 2009, Pages 853-866

  van der Zwaluw, Carmen S ^a   Engels, Rutger C M E ^a   Buitelaar, Jan ^a   Verkes, Robbert J ^a   Franke, Barbara ^a   Scholte, Ron H J ^a  

^a RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

Author keywords

Alcohol dependence; Alcoholism; DAT1; Dopamine transporter; Polymorphism; SLC6A3

Indexed keywords

ALDEHYDE DEHYDROGENASE ISOENZYME 2;

ALCOHOL WITHDRAWAL; ALCOHOLISM; CAUSAL ATTRIBUTION; DELIRIUM TREMENS; DOPAMINE TRANSPORTER GENE; GENE; GENE FREQUENCY; GENE FUNCTION; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; PHENOTYPE; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW; VARIABLE NUMBER OF TANDEM REPEAT;

ALCOHOL WITHDRAWAL DELIRIUM; ALCOHOLISM; CASE-CONTROL STUDIES; CONTINENTAL POPULATION GROUPS; DNA, COMPLEMENTARY; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; ENVIRONMENT; FAMILY; FEMALE; GENETIC VARIATION; HUMANS; MALE; MINISATELLITE REPEATS; RISK FACTORS; SEX CHARACTERISTICS; TANDEM REPEAT SEQUENCES;

EID: 66849117189     PISSN: 14622416     EISSN: 17448042     Source Type: Journal    
DOI: 10.2217/pgs.09.24     Document Type: Review

References (84)

1. Grant BF, Dawson DA, Stinson FS et al: The 12-month prevalence and trends in DSM-IV alcohol abuse and dependence: United States, 1991-1992 and 2001-2002. Drug Alcohol Depen. 74, 223-234 (2004).
2. Goldman D, Oroszi G, Ducci F: The genetics of addictions: uncovering the genes. Nat. Rev. Genet. 6, 521-532 (2005).
3. Kendler KS, Prescott CA, Neale MC, Pederson NL: Temperance board registration for alcohol abuse in a national sample of Swedish mate twins, born 1902 to 1949. Arch. Gen. Psych. 54, 178-184 (1997).
4. McGue M: The behavioral genetics of alcoholism. Curr. Dir. Psychol. Sci. 8, 109-115 (1999).
5. Pagan JL, Rose RJ, Viken RJ et al. Genetic and environmental influences on stages of alcohol use across adolescence and into young adulthood. Behav. Gen. 36, 483-497 (2006).
6. Prescott CA, Kendler KS: Genetic and environmental contributions to alcohol abuse and dependence in a population based sample of male twins. Am. J Psychiat. 156, 34-30 (1999).
7. Berridge KC, Robinson TE: What is the role of dopamine in reward: Hedonic impact, reward learning, or incentive salience. Brain Res. Rev. 28, 309-369 (1998).
8. Wise RA, Rompre PP: Brain dopamine and reward. Ann. Rev. Psychol. 40, 191-225 (1989).
9. Persico AM, Vandenbergh DJ, Smith SS, Uhl GR: Dopamine transporter gene polymorphisms are not associated with polysubstance abuse. Biol. Psychiat. 34, 265-267 (1993).
10. Uhl G: Neurotransmitter transporter (plus): A promising new gene family. Trends Neurosci. 15, 265-268 (1992).
11. Giros B, El Mestikawy S, Godinot N et al.: Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter. Mol. Pharmacol. 42, 383-390 (1992).
12. Drgon T, Lin Z, Wang G-J et al. Common human 5′ dopamine transporter (SLC6A3) haplotypes yield varying expression levels in vivo. Cell. Mol. Neurobiol. 26, 875-889 (2006).
13. Laine TPJ, Ahonen A, Torniainen P et al.: Dopamine transporters increase in human brain after alcohol withdrawal. Mol. Psychiatr. 4, 189-191 (1999).
14. Mash DC, Staley JK, Doepel FM et al.: Altered dopamine transporter densities in alcohol-preferring vervet monkeys. Neuroreport 7, 457-462 (1996).
15. Repo E, Kuikka JT, Bergstrom KA et al.: Dopamine transporter and D2-density in late-onset alcoholism. Psychopharmacology 147, 314-318 (1999).
16. Tiihonen J, Kuikka J, Bergström K et al.: Altered striatal dopamine re-uptake site densities in habitually violent and non-violent alcoholics. Nat. Med. 1, 654-657 (1995).
17. Heinz A, Ragan P, Jones DW et al.: Reduced central serotonin transporters in alcoholism. Am. J. Psychiat. 155, 1544-1549 (1998).
18. Volkow ND, Wang G, Fowler JS et al.: Decreases in dopamine receptors, not in dopamine transporters in alcoholics. Alcohol. Clin. Exp. Res. 20, 1594-1588 (1996).
19. Bannon MJ, Michelhaugh SK, Wang J, Sacchetti P: The human dopamine transporter gene: gene organization, transcriptional regulation, and potential involvement in neuropsychiatric disorders. Eur. Neuropsychopharm. 11, 449-455 (2001).
20. Grünhage F, Schutz TG, Müller DJ et al.: Systematic screening for DNA sequence variation in the coding region on the human dopamine transporter gene (DAT1). Mol. Psychiatr. 5, 275-282 (2000).
21. Kawarai T, Kawakami H, Yamamura Y, Nakamura S: Structure and organization of the gene encoding human dopamine transporter. Gene 195, 11-18 (1997).
22. Ueno S, Nakamura M, Mikami M et al.: Identification of a novel polymorphism of the human dopamine transporter (DAT1) gene and the significant association with alcoholism. Mol. Psychiatr. 4, 552-557 (1999).
23. Vandenbergh DJ, Thompson MD, Cook EH et al.: Human dopamine transporter gene: Coding region conservation among normal, Tourette's disorder, alcohol dependence and attention-deficit hyperactivity disorder. Mol. Psychiatr. 5, 283-292 (2000).
24. Vandenbergh DJ, Persico AM, Hawkins AL et al.: Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR. Genomics 14, 1104-1106 (1992).
25. Wernicke C, Smolka M, Gallinat J et al.: Evidence for the importance of the human dopamine transporter gene for withdrawal symptomatology of alcoholics in a German population. Neurosci. Lett. 333, 45-48 (2002).
26. Choi IG, Kee BS, Son HG et al.: Genetic polymorphisms of alcohol and aldehydogenase, dopamine and serotonin transporters in familial and non-familial alcoholism. Eur. Neuropsychopharm. 16, 123-128 (2006).
27. Kang AM, Palmatier MA, Kidd KK: Global variation of a 40-bp VNTR in the 32 untranslated region of the dopamine transporter gene (SLC6A3). Biol. Psychiat. 46, 151-160 (1999).
28. Mitchell RJ, Howlett S, Earl L et al.: Distribution of the 3′ VNTR polymorphism in the human dopamine transporter gene in world populations. Hum. Biol. 72, 295-304 (2000).
29. Santovito A, Cervella P, Selvaggi A et al.: DAT1 VNTR polymorphisms in a European and an African population: Identification of a new allele. Hum. Biol. 80, 191-198 (2008).
30. Conne B, Stutz A, Vassalli JD: The 3′ untranslated region of messenger RNA: a molecular 'hotspot' for pathology? Nat. Med. 6, 637-641 (2000).
31. Greenwood TA, Alexander M, Keck PE et al.: Segmental linkage disequilibrium within the dopamine transporter gene. Mol. Psychiatr. 7, 165-173 (2002).
32. Savelieva KV, Caudle WM, Findlay GS, Caron MG, Miller GW: Decreased ethanol preference and consumption in dopamine transporter female knock-out mice. Alcohol, Clin. Exp. Res. 26, 758-764 (2002).
33. Hall FS, Sofa I, Uhl GR: Sex-dependent modulation of ethanol consumption in vesicular monoamine transporter 2 (VMAT2) and dopamine transporter (DA7) knockout mice. Neuropsychopharmacol, 28, 620-628 (2003).
34. Fuke S, Suo S, Takahashi N, Koike H, Sasagawa N, Ishiura S: The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression. Pharmacogenomics J. 1, 152-156 (2001).
35. Heinz A, Goldman D, Jones DW et al.: Genotype influences in vivo dopamine transporter availability in human striatum. Neuropsychopharmacol. 22, 133-139 (2000).
36. Inoue-Murayama M, Adachi S, Mishima N et al.: Variation of variable number of tandem repeat sequences in the 3′-untranslated region of primate dopamine transporter genes that affects reporter gene expression. Neurosci. Lett. 334, 206-210 (2002).
37. Michelhaugh SK, Fiskerstrand C, Lovejoy A, Bannon MJ, Quinn PJ: The dopamine transporter gene (SLC6A3) variable number of tandem repeats domain enhances transcription in dopamine neurons. J. Neurochem. 79, 1033-1038 (2001).
38. Mill J, Asherson P, Browes C, D'Souza U, Craig I: Expression of the dopamine transporter gene is regulated by the 3′ UTR VNTR: Evidence from brain and lymphocytes using quantitative RT-PCR. Am. J. Med. Genet. 114, 975-979 (2002).
39. Miller GM, Madras BK: Polymorphisms in the 3′-untranslated region of human and monkey dopamine transporter genes affect reporter gene expression. Mol. Psychiatr. 7, 44-55 (2002).
40. VanNess SH, Owens MJ, Kilts CD: The variable number of tandem repeats element in DAT1 regulates in vitro dopamine transporter density. BMC Genet. 6, 55 (2005).
41. Foley PF, Loh EW, Innes DJ et al.: Association studies of neurotransmitter gene polymorphisms in alcohol Caucasians. Ann. NY Acad. Sci. 1025, 39-46 (2004).
42. Chen WJ, Chen CH, Huang J et al.: Genetic polymorphisms of the promoter region of dopamine D2 receptor and dopamine transporter genes and alcoholism among four aboriginal groups and Han Chinese in Taiwan. Psychiatr. Genet. 11, 187-195 (2001).
43. Le Strat Y, Ramoz N, Pickering P et al.: The 3′ part of the dopamine transporter gene DAT1/SLC6A3 is associated with withdrawal seizures in patients with alcohol dependence. Alcohol. Clin. Exp. Res. 32, 27-35 (2008).
44. Muramatsu T, Higuchi S: Dopamine transporter gene polymorphism and alcoholism. Biochem. Bioph. Res. Co. 211, 28-32 (1995).
45. Parsian A, Zhang ZH: Human dopamine transporter gene polymorphism (VNTR) and alcoholism. Am. J. Med. Genet. 74, 480-482 (1997).
46. Sander T, Harms H, Podschus J et al.: Allelic association of a dopamine transporter gene polymorphism in alcohol dependence with withdrawal seizures or delirium. Biol. Psychiat. 41, 299-304 (1997).
47. Samochowiec J, Kucharska-Mazur J, Grzywacz A et al.: Family-based and case-control study of DRD2, DAT, 5HTT, COMT genes polymorphisms in alcohol dependence. Neurosci. Lett. 410, 1-5 (2006).
48. Dobashi I, Inada T, Hadano K: Alcoholism and gene polymorphisms related to central dopaminergic transmission in the Japanese population. Psychiatr. Genet. 7, 87-91 (1997).
49. Bau CHD, Almeida S, Costa FT et al.: DRD4 and DAT1 as modifying genes in alcoholism: interaction with novelty seeking on level of alcohol consumption (scientific correspondence). Mol. Psychiatr. 6, 7-9 (2001).
50. Köhnke MD, Batra A, Kolb W et al.: Association of the dopamine transporter gene with alcoholism. Alcohol Alcoholism 40, 339-342 (2005).
51. Franke P, Schwab SG, Knapp M et al.: DAT1 gene polymorphism in alcoholism: a family-based association study. Biol. Psychiat. 45, 652-654 (1999).
52. Gorwood P, Limosin F, Batel P et al.: The A9 allele of the dopamine transporter gene is associated with delirium tremens and alcohol-withdrawal seizure. Biol. Psychiat. 53, 85-92 (2003).
53. Limosin F, Loze JY, Boni C et al.: The A9 allele of the dopamine transporter gene increases the risk of visual hallucinations during alcohol withdrawal in alcohol-dependent women. Nearosci. Lett. 362, 91-94 (2004).
54. 9 allele of the dopamine transporter gene. Am. J. Psychiat. 155, 474-478 (1998).
55. Yoshida A, Huang IY, Ikawa M: Molecular abnormality of an inactive aldehyde dehydrogenase variant commonly found in Orientals. Proc. Natl Acad. Sci. USA 81, 258-261 (1984).
56. Falk CT, Rubinstein P: Haplotype relative risks: An easy reliable way to construct a proper control sample for risk calculations. Ann. Hum. Genet. 51, 227-233 (1987).
57. Szot P, Reigel CE, White SS, Veith RC: Alterations in mRNA expression of systems that regulate neurotransmitter synaptic content in seizure-naive genetically epilepsy-prone fat (GEPR): transporter proteins and rate-limiting synthesizing enzymes for norepinephrine, dopamine and serotonin. Brain Res. Mol. Brain Res. 43, 233-245 (1996).
58. Sander T, Berlin W, Ostapowicz A et al.: Variation of the genes encoding the human glutamate EAA72, serotonin and dompaine transporters and susceptibility to idiopathic generalized epilepsy. Epilepsy Res. 41, 75-81 (2001).
59. van der Zwaluw CS, Engels RCME: Gene-environment interactions and alcohol use and dependence: current status and future challenges. Addiction (2008) (In press).
60. Flint J, Munafò MR: Forum: interactions between gene and environment. Curr. Opin. Psychiatr. 21, 315-317 (2008).
61. Yang B, Chan RCK, Jing J et al.: A meta-analysis of asociation studies between the 10-repeat allele of a VNTR polymorphism in the 3′-UTR of dopamine transporter gene and attention deficit disorder. Am. J. Med. Genet. 144B, 541-550 (2007).
62. Johann M, Bobbe G, Putzhammer A, Wodarz N: Comorbidity of alcohol dependence with attention-deficit hyperactivity disorder: Differences in phenotype with increased severity of the substance disorder, but not in genotype (serotonin transporter and 5-hydroxytryptamine-2c receptor). Alcohol. Clin. Exp. Res. 27, 1527-1534 (2003).
63. van der Zwaluw CS, van den Wildenberg E, Wiers RW et al.: Polymorphisms in the μ-opioid receptor gene (OPRM1) and the implications for alcohol dependence in humans. Pharmacogenomics 8, 1427-1436 (2007).
64. A receptor β3 subunit genes and alcoholism in Mexican-Americans. Alcohol 32, 45-52 (2004).
65. Cordell HJ: Epistasis, what it means, what it doesn't mean, and statistical methods to detect it in humans. Hum. Mol. Gen. 11, 2463-2468 (2002).
66. Poelen EA, Engels RC, van der Vorst H, Scholte RH, Vermulst AA: Best friends and alcohol consumption in adolescence: a within-family analysis. Drug Alcohol Depend. 88, 163-173 (2007).
67. van der Vorst H, Engels RCME, Dekovic M, Meeus W: Alcohol-specific rules, personality, and adolescents' alcohol use: a longitudinal person-environment study. Addiction 102, 1064-1075 (2007).
68. Windle M, Davies PT: Depression and heavy alcohol use among adolescents: concurrent and prospective relations. Dev. Psychopathol. 11, 823-844 (1999).
69. Nilsson KW, Sjoberg RL, Wargelius H et al.: The monoamine oxidase A (MAO-A) gene, family function and maltreatment as predictors of destructive behaviour during male adolescent alcohol consumption. Addiction 102, 389-398 (2007).
70. Nilsson KW, Sjöberg RL, Damberg M et al.: Role of serotonin transporter gene and family function in adolescent alcohol consumption. Alcohol. Clin. Exp. Res. 29, 564-570 (2005).
71. Rutter M: Nature, nurture, and development: From evangelism through science toward policy and practice. Child Dev. 73, 1-21 (1997).
72. Madrid GA, MacMurray J, Lee JW, Anderson BA, Comings DE: Stress as a mediating factor in the association between the DRD2 taq1 polymorphism and alcoholism. Alcohol 23, 117-122 (2001).
73. Caspi A, McClay J, Moffit TE et al.: Role of genotype in the cycle of violence in maltreated children. Science 297, 851-854 (2002).
74. Nilsson K, Sjoberg R, Damberg M et al.: Role of monoamine oxidase A genotype and psychosocial factors in male adolescent criminal activity. Biol. Psychiat. 59, 121-127 (2005).
75. van der Zwaluw CS, Engels Rc, Vermulst AA: Interaction between dopamine D2 receptor genotype and parental rule-setting in adolescent alcohol use: evidence for a gene-parenting interaction. Mol. Psychiatr. (2009) (Epub ahead of print).
76. Uher R: Forum: The case for gene-environment interactions in psychiatry. Curr. Opin. Psychiatr. 21, 318-321 (2008).
77. Guerrini I, Cook CH, Kest W et al.: Genetic linkage analyses supports the presence of two susceptibility loci for alcoholism and heavy drinking on chromosome 1p22.1-11.2 and 1q21.3-24.2. BMC Genetics 6 (2005).
78. Prescott CA, Sullivan PF, Kuo P-H et al.: Genomewide linkage study in the Irish affected sib pair study of alcohol dependence: evidence for a susceptibility region for symptoms of alcohol dependence on chromosome 4. Mol. Psychiatr. 11, 603-611 (2006).
79. Gottesman II, Gould TD: The endophenotype concept in psychiatry: etymology and strategic intentions. Am. J. Psychiat. 160, 636-645 (2003).
80. Dick DM, Jones K, Saccone N et al.: Endophenotypes successfully lead to gene identification: results from the collaborative study on the genetics of alcoholism. Behav. Genet. 36, 112-126 (2006).
81. Rietschel M: Environment is important. Curr. Opin. Psychiatr. 21, 323-324 (2008).
82. Chakravarti A, Little P: Nature, nurture and human disease. Nature 421, 412-414 (2003).
83. Buckland PR: Will we ever find the genes for addiction? Addiction 103, 1768-1776 (2008).
84. Purcell S, Cherny SS, Sham PC: Genetic power calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 19, 149-150 (2003).